277 related articles for article (PubMed ID: 16421589)
1. The telomeric PARP, tankyrases, as targets for cancer therapy.
Seimiya H
Br J Cancer; 2006 Feb; 94(3):341-5. PubMed ID: 16421589
[TBL] [Abstract][Full Text] [Related]
2. Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics.
Seimiya H; Muramatsu Y; Ohishi T; Tsuruo T
Cancer Cell; 2005 Jan; 7(1):25-37. PubMed ID: 15652747
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of tankyrase inhibition in whole cells.
Ohishi T; Tsuruo T; Seimiya H
Methods Mol Biol; 2007; 405():133-46. PubMed ID: 18369822
[TBL] [Abstract][Full Text] [Related]
4. Mechanism-based combination telomerase inhibition therapy.
Shay JW; Wright WE
Cancer Cell; 2005 Jan; 7(1):1-2. PubMed ID: 15652743
[TBL] [Abstract][Full Text] [Related]
5. TIN2 is a tankyrase 1 PARP modulator in the TRF1 telomere length control complex.
Ye JZ; de Lange T
Nat Genet; 2004 Jun; 36(6):618-23. PubMed ID: 15133513
[TBL] [Abstract][Full Text] [Related]
6. Telomere elongation by a mutant tankyrase 1 without TRF1 poly(ADP-ribosyl)ation.
Muramatsu Y; Tahara H; Ono T; Tsuruo T; Seimiya H
Exp Cell Res; 2008 Mar; 314(5):1115-24. PubMed ID: 18221737
[TBL] [Abstract][Full Text] [Related]
7. Telomerase inhibitors in cancer therapy: current status and future directions.
Incles CM; Schultes CM; Neidle S
Curr Opin Investig Drugs; 2003 Jun; 4(6):675-85. PubMed ID: 12901225
[TBL] [Abstract][Full Text] [Related]
8. Tankyrase-1 assembly to large protein complexes blocks its telomeric function.
Hatsugai K; Ohishi T; Sugimoto Y; Seimiya H
FEBS Lett; 2010 Sep; 584(18):3885-90. PubMed ID: 20696165
[TBL] [Abstract][Full Text] [Related]
9. Telomere maintenance mechanisms as a target for drug development.
Bearss DJ; Hurley LH; Von Hoff DD
Oncogene; 2000 Dec; 19(56):6632-41. PubMed ID: 11426649
[TBL] [Abstract][Full Text] [Related]
10. Role for the related poly(ADP-Ribose) polymerases tankyrase 1 and 2 at human telomeres.
Cook BD; Dynek JN; Chang W; Shostak G; Smith S
Mol Cell Biol; 2002 Jan; 22(1):332-42. PubMed ID: 11739745
[TBL] [Abstract][Full Text] [Related]
11. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
Kelland LR
Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of tankyrase 1 in human gastric cancer cells enhances telomere shortening by telomerase inhibitors.
Zhang H; Yang MH; Zhao JJ; Chen L; Yu ST; Tang XD; Fang DC; Yang SM
Oncol Rep; 2010 Oct; 24(4):1059-65. PubMed ID: 20811689
[TBL] [Abstract][Full Text] [Related]
13. Telomerase as a target for cancer therapy.
Parkinson KE
Curr Opin Investig Drugs; 2005 Jun; 6(6):605-10. PubMed ID: 15988912
[TBL] [Abstract][Full Text] [Related]
14. Targeting telomeres and telomerase.
De Cian A; Lacroix L; Douarre C; Temime-Smaali N; Trentesaux C; Riou JF; Mergny JL
Biochimie; 2008 Jan; 90(1):131-55. PubMed ID: 17822826
[TBL] [Abstract][Full Text] [Related]
15. Telomeres and telomerase: Biological and clinical importance in dogs.
Nasir L
Vet J; 2008 Feb; 175(2):155-63. PubMed ID: 17398127
[TBL] [Abstract][Full Text] [Related]
16. Tankyrases as drug targets.
Lehtiö L; Chi NW; Krauss S
FEBS J; 2013 Aug; 280(15):3576-93. PubMed ID: 23648170
[TBL] [Abstract][Full Text] [Related]
17. Telomeres and telomerase as targets for anticancer drug development.
Olaussen KA; Dubrana K; Domont J; Spano JP; Sabatier L; Soria JC
Crit Rev Oncol Hematol; 2006 Mar; 57(3):191-214. PubMed ID: 16469501
[TBL] [Abstract][Full Text] [Related]
18. Telomere and telomerase as targets for cancer therapy.
Tian X; Chen B; Liu X
Appl Biochem Biotechnol; 2010 Mar; 160(5):1460-72. PubMed ID: 19412578
[TBL] [Abstract][Full Text] [Related]
19. Tankyrase as a Novel Molecular Target in Cancer and Fibrotic Diseases.
Lakshmi TV; Bale S; Khurana A; Godugu C
Curr Drug Targets; 2017; 18(10):1214-1224. PubMed ID: 27425647
[TBL] [Abstract][Full Text] [Related]
20. Targeting the limitless replicative potential of cancer: the telomerase/telomere pathway.
Kelland L
Clin Cancer Res; 2007 Sep; 13(17):4960-3. PubMed ID: 17785545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
